23 August 2017
Data MATRIX, a St. Petersburg start-up developing clinical data processing solutions, has opened a rep office in Munich, in southern Germany, and joined the Bavarian biotech cluster, Russian portal Firrma.ru reported , citing a source in the start-up.
Data MATRIX is reportedly expecting the new office to facilitate the Russian company’s interaction with international customers. The start-up also hopes to find prospective partners among Bavarian cluster resident companies.
The St. Pete start-up will offer its new clients the company’s existing products and services, as well as its new R&D product for clinical trial control called CTMS.
Set up three years ago, Data MATRIX has come up with special software to arrange and manage clinical trials. Its current portfolio reportedly includes more than 100 projects for pharmas, biotech companies, and contract research organizations (CROs).
At the end of last year Data MATRIX raised a reported $2.8m from the Russian government-owned Internet Initiatives Development Fund (known in Russia under the FRII abbreviation) and Primer Capital, a Russian private venture fund. The start-up has used the money to step up project development and prepare for foreign market entry.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024